Expanded Access Protocol Using 131I-MIBG

ClinicalTrials.gov ID: NCT01590680

Public ClinicalTrials.gov record NCT01590680. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open Label, Expanded Access Protocol Using 131I-metaiodobenzylguanidine (131I-MIBG) Therapy in Patients With Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma (Not Eligible for Approved Treatment)

Study identification

NCT ID: NCT01590680
Recruitment status: Available
Study type: Expanded access
Phase: Not listed
Lead sponsor: Jubilant DraxImage Inc.; Industry
Enrollment: Not listed

Conditions and interventions

Conditions

Interventions

I-131 MIBG Radiation

Radiation

Eligibility (public fields only)

Age range: 12 Months and older
Sex: All
Healthy volunteers: Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Not listed
Primary completion: Not listed
Completion: Not listed
Last update posted: Feb 27, 2023

United States locations

U.S. sites: 19
U.S. states: 14
U.S. cities: 19

Facility	City	State	ZIP	Site status
Children's Hospital Los Angeles	Los Angeles	California	90027	Available
Children's Hospital Colorado	Aurora	Colorado	80045	Available
Children's Healthcare of Atlanta	Atlanta	Georgia	30322	Available
University of Chicago Medical Center	Chicago	Illinois	60637	Available
Dana-Farber Cancer Institute	Boston	Massachusetts	02215	Available
Michigan Medicine, University of Michigan	Ann Arbor	Michigan	48105	Available
Washington University School of Medicine	St Louis	Missouri	63110	Available
North Carolina Children's Hospital	Chapel Hill	North Carolina	27599	Available
Carolinas Medical Center/ Levine Children's Hospital	Charlotte	North Carolina	28203	Available
Duke University Medical Center	Durham	North Carolina	27710	Available
Cincinnati Children's Hospital	Cincinnati	Ohio	45229-3039	Available
The Children's Hospital of Philadelphia	Philadelphia	Pennsylvania	19104	Available
UPMC Children's Hospital of Pittsburgh	Pittsburgh	Pennsylvania	15224	Available
Monroe Carell Jr. Children's Hospital at Vanderbilt	Nashville	Tennessee	37232	Available
Children's Medical Center Dallas	Dallas	Texas	75235	Available
Cook Children's Medical Center	Fort Worth	Texas	76104	Available
Baylor College of Medicine, Texas Children's Hospital	Houston	Texas	77035	Available
Seattle Children's Hospital	Seattle	Washington	98105	Available
University of Wisconsin Hospital and Clinics, American Family Children's Hospital	Madison	Wisconsin	53792	Available

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01590680, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 27, 2023 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01590680 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →